Ms. Katie Savastano reports

BAUSCH HEALTH ANNOUNCES NEXT STEPS IN FINANCING INITIATIVE WITH J.P. MORGAN

Bausch Health Companies Inc. has provided an update on its financing plans. The company has engaged J.P. Morgan in connection with the company's previously announced financing objectives.

Any transactions would be subject to market and other conditions, and there can be no assurance that the company will be able to complete any transaction on acceptable terms or at all.

About Bausch Health Companies Inc.

Bausch Health is a global, diversified pharmaceutical company, enriching lives through its relentless drive to deliver better health care outcomes. It develops, manufactures and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through its controlling interest in Bausch + Lomb Corp. Its ambition is to be a globally integrated health care company, trusted and valued by patients, HCPs, employees and investors.

We seek Safe Harbor.